Developed and launched an innovative mental wellness brand with the vision to inspire purpose-driven habits that aid meditation and mindfulness practice to combat the ongoing mental health crisis. Designed social media identity, website and outreach initiatives to promote thought leadership in the mental wellness space.- Researched consumer trends and created product line to meet mental health need of target market.- Successfully secured capital investment required for initial start-up through product launch and beyond.- Managed all operations across sourcing, vendor selection, cost analysis, and inventory planning.- Designed product packaging, customer acquisition strategies, direct to consumer advertisements, website and social media marketing.

Taught Pre-AP Biology classes across 4 sections of high school students. Fostered critical thinking and independence of thought by praising insightful curiosity and creating space for students to think their way through problem solving. Aligned lesson planning to STEM curriculum that integrates technology, connects math and science, and created experiences for students to take ownership of their learning.- Used formal and informal assessment data to direct instruction and the path to student mastery of standards- Built a warm and inclusive classroom environment, implementing restorative practices.- Ensured that all lessons and assignments designed and presented to students were rigorous and reflect ambitious aspirations of meeting the challenges of academic excellence.- Actively participated in grade-level meetings, collaborative planning, and summer institute of professional teacher development - Established and maintained strong relationships with students and families by meeting them where they are at and truly listening to their diverse perspectives

Built relationships with medical providers and associated health systems to drive increased adoption of our patient-specific surgical tools and software. Led strategic commercial planning and product education to enable the launch of distribution of our anatomical models.- Developed formalized business development and sales processes focusing on in-network expansion, target prioritization, and tracking key sales metrics- Acted as a trusted advisor to surgical center management and value analysis groups to establish health system partnerships that streamlined ordering and reimbursement of our products for surgeons.- Delivered demonstrations of our software platform and iPhone app to improve customer and patient satisfaction.

Prospected, pitched, and provided white-glove service solutions to established and potential clients in the research and development departments of Bay Area life science companies. Spearheaded the go-to-market strategy and the sales cycle roll-out of an acquired boutique brand.- Managed launch and day to day program operations of the top all-time company account.- Identified decision-makers, key stakeholders, and opportunities to enhance challenging relationships.- Led competitive intelligence efforts, contract negotiation/execution, and extensive networking event outreach.

Designed & delivered innovative yet impactful solutions to solve complex business problems in collaboration with pharma/biotech and specialty service provider clients. Developed patient service, marketing, channel, and distribution strategies that achieved the result of optimizing the value of healthcare delivered to patients. - Identified key influencers and business drivers of the intricate relationships our clients had with distribution, dispensing, and patient service providers. Synthesized internal client concerns and forecasts with external perspectives, business case analogs, and industry trends to deliver persuasive presentations, which empowered senior leadership to adopt transformative approaches that resulted in optimal channel performance and patient experience.- Built consensus across executives, stakeholders, and team members to derive quantifiable solutions for clients with deliverables including strategic analysis of gaps or inefficiencies in patient services, channel distribution, market share protection, and generic/biosimilar competition.

Provided strategic management consulting support for pharma and biotech clients requiring assistance with a wide range of engagements. Synthesized complex client challenges and then owned and executed defined project deliverables.- Provided oversight of transition from waterfall to agile methods of planning, tracking, and documentation for project teams developing IT solutions supporting patient access to more affordable medicines.- Advised the implementation of an increasingly formalized, nimble, and streamlined approach to the commercial innovation approval pathway, which reduced approval turnaround time from 18 down to 6 months.- Designed and developed business process maps and associated standard operating procedures capturing the activities performed by the client to meet the federal mandate to allocate and report aggregate spend for individual healthcare professionals.- Architected the timeline, communications, and training needed for the user adoption strategy to deploy Google apps to a client’s new sales force at a national sales meeting occurring in less than 3 months.

Prepared for the new drug application submission of two Phase III HIV studies, which successfully demonstrated improved safety over comparators, through reviews of data listings and monitoring visit reports in order to instruct monitors and medical sites on corrective action plans for resolution of all related issues, discrepancies, and deviations. Led the reconciliation of investigator financial interest reporting for these studies along with four other late stage HIV studies submitting new drug applications.

Provided logistical support in management of a multitude of Phase I - II, insourced, outsourced, oncology, immune disease, and Alzheimer’s studies. Coordinated communication between the study team and medical sites, as well as investigator meeting planning. Managed vendor relationships, and led financial meetings to discuss budgetary concerns. Performed data listing review to ensure compliance with regulatory standards. Developed, maintained, and managed study documentation. Created tracking systems in order to report study metrics, manage payments and supplies. Collected, maintained and reconciled regulatory documentation within the Trial Master File.

Developed consensus approval from senior leadership on process to segment the $380 million peritoneal dialysis market. Created a readily understandable segmentation framework using geographic and profitability measures that field sales would incorporate with a qualitative assessment of each clinic’s peritoneal dialysis adoption. Ensured cross functional management stakeholders found the framework actionable for resource allocation. Revised an external field sales presentation of Baxter’s differentiated value proposition by creating a metric driven scorecard that articulates the value Baxter currently provides and could going forward to peritoneal dialysis customers. Worked with Finance to establish the most pragmatic way to measure the value Baxter provides. Created a cost-to-serve calculation for all Baxter support activities. Provided the framework needed to customize the scorecard measures so the tool could maximize the value of activities offered to meet needs of each segment and facility.

Led three worldwide Ridaforolimus study teams in transition to Merck & Co. as part of a $200Mn company partnership. Successfully oversaw transfer of studies within the required 3 month timeframe. Directed efforts of Phase 1 Ponatinib study team credited with producing data analysis positioning oncology drug for Phase II orphan drug status. Reported on progress directly to executive level management.Assisted in development of the protocol and other essential study materials as well as regulatory preparation of North American study sites for FDA Phase II clinical trial for Ponatinib.Managed external relationships with vendors tasked with specialty testing, data collection/processing, and database maintenance essential to completion and documentation of drug trials.

Led six-person team that performed in-house monitoring activities for three clinical drug trials, all of which successfully passed FDA Phase III trial approval and went to market with revenue expectations of $12Bn. Mentored new members of the team on study required activities and company standard operating procedures.Assisted with clinical trial management, including providing performance reports to sponsors of two studies on site status, monitoring visit schedules, shipment tracking, etc.

Collected, cultured, and analyzed clinical samples in support of the company’s Phase I clinical trial to use blue light therapy to eradicate H. pylori, carcinogenic bacteria, in the stomach.Designed and led experiments coordinated with the CEO to test if blue light therapy could be enhanced with additional light or adjuvants.

Performed research at Harvard Medical School's Cutaneous Biology Research Center to ascertain which genes are responsible for cutaneous development in mammals.

Mapped a generator's possible power, voltage and current outputs. Measured and logged temperature increase of varying volumes of saline in a cadaver's knee when a probe was run by the generator at multiple power levels.Created and performed an experimental design to assess the temperature rise of skin at a return pad attached to the aforementioned generator.